Lee Jeong-Chae, Jung Ha-Na, Kim Ju, Woo Won-Hong, Jeong Woo-Yeal, Chung Gook-Hyun, Jang Yong-Suk
Division of Biological Sciences and Research Center of Bioactive Materials, Chonbuk National University, Chonju, South Korea.
Clin Chim Acta. 2003 Mar;329(1-2):133-42. doi: 10.1016/s0009-8981(03)00014-7.
In previous studies, we showed that oral administration of traditional Korean medicines, Soamsan (SA) and Bo-yang-hwan-o-tang (BHT), modulated antigen-specific immune responses in mice.
We attempted to strengthen cell-mediated immune responses in mice using two mixed prescriptions composed mainly of components used in SA and/or BHT. The effect of oral administration of the medicines on the induction of antigen-specific immune responses was investigated using hen egg-white lysozyme (HEL) as a model antigen system.
Following oral administration, HEL-specific cellular immune responses were enhanced in HEL low-responder mice, and the concentrations of gamma interferon (IFN-gamma), but not interleukin (IL)-4, increased significantly. In addition, the prescriptions decreased the level of HEL-specific antibodies of the immunoglobulin (Ig)G1 subtype, which is associated with helper T lymphocyte (Th2) cell stimulation. Moreover, the presence of the medicines in vitro significantly increased IFN-gamma production from mouse splenocytes, and the magnitude of the increase was closely associated with glycoprotein concentrations.
The Korean prescriptions enhanced anti-HEL-specific cellular immune responses by selectively priming specific subtypes of the helper T cell population. Consequently, they might be useful therapy for patients who need enhanced Th1, or to suppress Th2 immune responses.
在先前的研究中,我们发现口服韩国传统药物寿山石(SA)和保阳还五汤(BHT)可调节小鼠的抗原特异性免疫反应。
我们试图使用两种主要由SA和/或BHT中使用的成分组成的混合方剂来增强小鼠的细胞介导免疫反应。以蛋清溶菌酶(HEL)作为模型抗原系统,研究口服这些药物对抗原特异性免疫反应诱导的影响。
口服后,HEL低反应小鼠中HEL特异性细胞免疫反应增强,γ干扰素(IFN-γ)浓度显著增加,而白细胞介素(IL)-4浓度未增加。此外,这些方剂降低了与辅助性T淋巴细胞(Th2)细胞刺激相关的免疫球蛋白(Ig)G1亚型的HEL特异性抗体水平。此外,药物在体外的存在显著增加了小鼠脾细胞产生的IFN-γ,且增加幅度与糖蛋白浓度密切相关。
韩国方剂通过选择性启动辅助性T细胞群体的特定亚型来增强抗HEL特异性细胞免疫反应。因此,它们可能对需要增强Th1或抑制Th2免疫反应的患者有用。